statistiche ricercatore

ACCOLLA, ROBERTO

Distribuzione geografica

Continente	#
NA - Nord America	17.857
EU - Europa	14.568
AS - Asia	3.101
OC - Oceania	13
Continente sconosciuto - Info sul continente non disponibili	12
SA - Sud America	9
AF - Africa	4
Totale	35.564

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	17.739
IT - Italia	7.578
UA - Ucraina	2.738
TR - Turchia	1.396
DE - Germania	1.123
SE - Svezia	1.045
VN - Vietnam	930
CN - Cina	686
IE - Irlanda	664
FI - Finlandia	608
GB - Regno Unito	361
FR - Francia	215
CA - Canada	116
RU - Federazione Russa	114
IN - India	49
BE - Belgio	41
NL - Olanda	19
EU - Europa	12
CH - Svizzera	9
AU - Australia	8
PK - Pakistan	8
AT - Austria	5
CZ - Repubblica Ceca	5
ES - Italia	5
HK - Hong Kong	5
JP - Giappone	5
NZ - Nuova Zelanda	5
MY - Malesia	4
RO - Romania	4
AR - Argentina	3
BR - Brasile	3
BY - Bielorussia	3
DK - Danimarca	3
HR - Croazia	3
KR - Corea	3
LU - Lussemburgo	3
PL - Polonia	3
RS - Serbia	3
SG - Singapore	3
AL - Albania	2
BN - Brunei Darussalam	2
GR - Grecia	2
HU - Ungheria	2
KZ - Kazakistan	2
LV - Lettonia	2
AE - Emirati Arabi Uniti	1
AZ - Azerbaigian	1
BA - Bosnia-Erzegovina	1
BD - Bangladesh	1
BG - Bulgaria	1
CL - Cile	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
EG - Egitto	1
GH - Ghana	1
IL - Israele	1
LI - Liechtenstein	1
LK - Sri Lanka	1
ME - Montenegro	1
MK - Macedonia	1
MX - Messico	1
NG - Nigeria	1
NO - Norvegia	1
PE - Perù	1
PH - Filippine	1
PT - Portogallo	1
SK - Slovacchia (Repubblica Slovacca)	1
TH - Thailandia	1
TW - Taiwan	1
VE - Venezuela	1
Totale	35.564

Salva come PNG Salva come JPEG

Città	#
Milan	5.717
Fairfield	2.140
Jacksonville	2.109
Woodbridge	1.748
Chandler	1.586
Ann Arbor	1.181
Houston	1.131
Ashburn	1.105
Wilmington	906
Seattle	905
Izmir	763
Princeton	718
Dearborn	698
Cambridge	693
Dublin	662
Nyköping	544
Dong Ket	430
Rome	411
Como	243
San Mateo	242
Beijing	231
San Diego	165
Ogden	141
New York	133
Toronto	101
Düsseldorf	83
Verona	69
Hefei	62
Boardman	50
Nanjing	47
Kunming	45
London	43
Norwalk	42
Brussels	39
Helsinki	34
Los Angeles	34
Jinan	33
Pune	32
Washington	31
Kocaeli	29
Guangzhou	27
Redwood City	20
Fuzhou	19
Falls Church	18
Phoenix	16
Nanchang	15
Auburn Hills	14
Edinburgh	14
Kilburn	14
Hebei	12
Wuhan	12
Frankfurt am Main	11
Berlin	10
Changsha	10
Hangzhou	10
Xian	10
Magnago	9
Shenyang	9
Amsterdam	8
Ponte Lambro	8
Zhengzhou	8
Chengdu	7
Chongqing	7
Huzhou	7
Ningbo	7
Redmond	7
Rozzano	7
Baotou	6
Chicago	6
Stockholm	6
Sydney	6
Aprilia	5
Chiswick	5
Hounslow	5
Indiana	5
Islington	5
Madrid	5
Perugia	5
Prescot	5
San Francisco	5
Vienna	5
Wandsworth	5
Wenzhou	5
Zurich	5
High Point	4
Lausanne	4
Paris	4
Quzhou	4
Shaoxing	4
Sialkot	4
Simi Valley	4
Taiyuan	4
Timisoara	4
Turin	4
West Jordan	4
Wilnsdorf	4
Acton	3
Auckland	3
Belgrade	3
Copenhagen	3
Totale	25.841

Salva come PNG Salva come JPEG

Nome	#
Unsung hero Robert C. Gallo	196
Translation and assembly of HLA-DR antigens in Xenopus oocytes injected with mRNA from a human B-cell line	184
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells	181
Class II Transactivator-Induced MHC Class II Expression in Pancreatic Cancer Cells Leads to Tumor Rejection and a Specific Antitumor Memory Response	179
Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1	177
Host defense mechanisms against pathogens	172
Functional significance of polymorphism among MHC class II gene promoters	172
Isolation of cDNA clones for the p33 invariant chain associated with HLA-DR antigens	171
Investigating Human T Cell Lymphotropic Retrovirus (HTLV) tax function with molecular and immunophenotypic techniques	171
Analysis of the structural heterogeneity and polymorphism of human Ia antigens. Four distinct subsets of molecules are coexpressed in the Ia pool of both DR1,1 homozygous and DR3,W6 heterozygous B cell lines	170
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)	170
Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb	168
Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy	166
Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma	166
Detection of human chromosomes in somatic cell hybrids by PCR analysis	166
Demonstration at the single cell level of the existence of distinct clusters of epitopes in two predefined human Ia molecular subsets	164
Transcriptional regulation of MHC class II genes	164
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells	164
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state	163
Localization, quantification and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	163
Sandwich enzyme immunoassay using three monoclonal antibodies against different epitopes of carcinoembryonic antigen "CEA".	161
Double-stranded deoxyribonucleic acid binds to HLA class II molecules and inhibits HLA class II-mediated antigen presentation	160
Human adipose-derived stem cells promote vascularization of collagen-based scaffolds transplanted into nude mice	159
CIITA-related block of HLA class II expression, upregulation of HLA class I, and heterogeneous expression of immune checkpoints in hepatocarcinomas: implications for new therapeutic approaches	159
Antibody-mediated activation of a deletion-mutant b-galactosidase defective in the a-region	157
Divergent evolution in the mechanisms controlling major histocompatibility complex class II gene transcription in mouse and human	157
An enhancer factor defect in a mutant Burkitt lymphoma cell line	157
Picosecond-resolved FRET on non-amplified DNA for identifying individuals genetically susceptible to type-1 diabetes	156
CIITA-driven MHC-II positive tumor cells: preventive vaccines and superior generators of antitumor CD4(+) T lymphocytes for immunotherapy	155
The MHC class II transactivator: prey and hunter in infectious diseases	153
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response	152
APC gene mutations and allelic losses in sporadic ampullary tumours: evidence of genetic difference from tumours associated with familial adenomatous polyposis	152
HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients	151
Antibody-mediated activation of genetically defective Escherichia coli beta-galactosidases by monoclonal antibodies produced by somatic cell hybrids	150
Cell lineage-specific and developmental stage-specific controls of MHC class-II-antigen expression.	148
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	148
Subsets of human Ia-like molecules defined by monoclonal antibodies	148
In vivo modification of major histocompatibility complex class II DRA promoter occupancy mediated by the AIR-1 trans-activator	148
New strategies of mammary cancer vaccination	147
Biochemical aspects of human Ia molecules	147
SUSCEPTIBILITY OF HUMAN-MOUSE T-CELL HYBRIDS TO HIV-PRODUCTIVE INFECTION	147
Somatic cell hybrids producing antibodies specific to human fibronectin.	146
Superinfection by Epstein-Barr virus of a subset of Raji cells is independent of HLA class-II antigens	146
The MHC Class II transactivator CIITA inhibits the persistent activation of NF-kB by Tax-1	146
H2-RESTRICTED RECOGNITION OF CLONED HLA CLASS-I GENE-PRODUCTS EXPRESSED IN MOUSE CELLS	144
Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells.	143
ras-Family gene mutations in neoplasia of the ampulla of Vater	143
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators	143
Monoclonal antibodies against carcinoembryonic antigen (CEA) used in solid-phase enzyme immunoassay	142
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells	142
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA	142
Ia-negative B-cell variants reveal a coordinate regulation in the transcription of the HLA class II gene family	142
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection and specific anti-tumor memory.	141
The importance of cross-reactions between species: mouse allo-anti-Ia monoclonal antibodies as a powerful tool to define human Ia subsets	141
A girl with Diabetes and severe Combined Immunodeficiency from Adenosine Deaminase Deficiency	141
Binding of one monoclonal antibody to human Ia molecules can be enhanced by a second monoclonal antibody	140
Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen	139
Localization, quantization and interaction with host factors of endogenous HTLV-1 HBZ protein in infected cells and ATL	139
Distinct forms of both a and b subunits are present in the human Ia molecular pool	138
Human interleukin-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells	138
Structural analysis of the CD69 early activation antigen by two monoclonal antibodies directed to different epitopes.	137
IL-2 mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens.	136
The MHC class II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation.	135
Interspecies somatic T cell hybrids as biological tools for studying gene expression during T cell development	135
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication	134
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy	133
Allogeneic mixed lymphocyte reactions in humans : Pretreatment of either the stimulator or the responder cell population with monoclonal anti-Ia antibodies leads to an inhibition of cell proliferation	132
Monoclonal antibodies specific for carcinoembryonic antigen and produced by two hybrid cell lines.	132
aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression.	132
Idiotype-specific neonatal suppression of phosphorylcholine-responsive B cells.	132
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific anti-tumor memory	132
Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors.	131
Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines.	131
Different staphylococcal enterotoxins bind preferentially to distinct major histocompatibility complex class II isotypes	131
Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.	131
A family of trans-acting factors with distinct regulatory functions control expression of MHC class II genes.	131
Stable integration of mouse DNA into Ia-negative human B-lymphoma cells causes reexpression of the human Ia-positive phenotype.	131
Screening transplant donors for HTLV-1 and -2	131
The HLA class II transcriptional activator blocks the function of HIV-1 Tat and inhibits viral replication	130
Reducing the global burden of HTLV-1 infection: An agenda for research and action	130
MHC: Orchestrating the immune response	129
Structural analysis of human Ia antigens reveals the existence of a fourth molecular subset distinct from DP, DQ, and DR molecules.	128
Loss of a DNA-protein complex correlates with extinguished major histocompatibility complex class II expression in a human B cell.	128
Distinct regulation of HLA class II and class I cell surface expression in THP-1 macrophage cell line after bacterial phagocytosis	127
Irradiated CIITA-positive mammary adenocarcinoma cells act as a potent antitumor preventive vaccine by inducing tumor-specific CD4+ T cell priming and CD8+ T cell effector functions.	127
Tumor rejection by gene transfer of the MHC class II transactivator in murine mammary adenocarcinoma cells	126
MHC class II gene regulation: some historical considerations on a still ontogenetic and phylogenetic puzzle	126
Neonatal Fc receptor is involved in the protection of fibrinogen after its intake in peripheral blood mononuclear cells	126
Trans-acting element(s) operating across species barriers positively regulate expression of major histocompatibility complex class II genes.	125
Assessment of the DQB1-DQA1 complete genotype allows best prediction for IDDM	125
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1.	125
The MHC-II transactivator CIITA inhibits Tax-1-mediated HTLV-1 expression and NF-kB activation	125
Active suppression of the class II transactivator-encoding AIR-1 locus is responsible for the lack of major histocompatibility complex class II gene expression observed during differentiation from B cells to plasma cells.	124
HLA-DQ genotype in early onset insulin dependent diabetes mellitus	124
HLA-DQB1 typing of north east Italian IDDM patients using amplified DNA, oligonucleotide probes and a rapid DNA-enzyme immunoassay (DEIA).	122
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization	122
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma	122
CIITA-driven MHC class II expressing tumor cells as antigen presenting cell performers: Toward the construction of an optimal anti-tumor vaccine	122
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA	121
Interferon-inducible TRIM22 contributes to maintenance of HIV-1 proviral latency in T cell lines	121
Totale	14.477

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	106.772
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	106.772

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	1.912	0	0	0	0	0	0	0	0	0	0	674	1.238
2019/2020	6.263	264	191	258	1.107	343	729	1.037	824	434	543	82	451
2020/2021	5.023	61	612	181	487	124	517	165	493	806	232	462	883
2021/2022	3.241	392	414	271	231	114	95	124	219	158	470	279	474
2022/2023	4.385	471	152	271	469	344	952	6	641	639	139	172	129
2023/2024	8.626	1.439	1.410	1.540	1.543	1.652	547	64	111	274	44	2	0
Totale													35.762